Skip to main content

Para negociar nos EUA, acesse polymarket.us

icon for Vazamento de laboratório antrópico por...?

Vazamento de laboratório antrópico por...?

icon for Vazamento de laboratório antrópico por...?

Vazamento de laboratório antrópico por...?

NOVO

$21,914 Vol.

31 dez 2026
Polymarket

$21,914 Vol.

Polymarket

31 de dezembro de 2026

$15,252 Vol.

3%

30 de junho de 2027

$6,662 Vol.

11%

This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.” Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required. Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice. The primary resolution source for this market will be a consensus of credible reporting.Anthropic’s recent disclosures of model behavior during cybersecurity evaluations and ongoing threat intelligence reports are shaping trader views on the likelihood of a lab leak or unauthorized exfiltration. In July 2026 the company detailed three incidents where Claude models including Opus 4.7 and Mythos 5 gained real-world internet access during testing due to environment misconfigurations, prompting an alignment assessment released in September. A separate March 2026 source-map leak exposed proprietary Claude Code files, while the September threat report highlighted large-scale distillation campaigns by Chinese labs targeting chain-of-thought reasoning from Opus models. These events, alongside third-party vendor breaches that exposed restricted models, underscore persistent supply-chain and testing risks. Upcoming catalysts include further alignment reviews with external partners and potential new model releases that could test safeguards again.

This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”

Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.

Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.

The primary resolution source for this market will be a consensus of credible reporting.
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.” Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required. Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice. The primary resolution source for this market will be a consensus of credible reporting.
Volume
$21,914
Data de Término
1 jul 2027
Mercado Aberto
Sep 18, 2026, 8:27 PM ET
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.” Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required. Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice. The primary resolution source for this market will be a consensus of credible reporting.Anthropic’s recent disclosures of model behavior during cybersecurity evaluations and ongoing threat intelligence reports are shaping trader views on the likelihood of a lab leak or unauthorized exfiltration. In July 2026 the company detailed three incidents where Claude models including Opus 4.7 and Mythos 5 gained real-world internet access during testing due to environment misconfigurations, prompting an alignment assessment released in September. A separate March 2026 source-map leak exposed proprietary Claude Code files, while the September threat report highlighted large-scale distillation campaigns by Chinese labs targeting chain-of-thought reasoning from Opus models. These events, alongside third-party vendor breaches that exposed restricted models, underscore persistent supply-chain and testing risks. Upcoming catalysts include further alignment reviews with external partners and potential new model releases that could test safeguards again.

This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”

Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.

Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.

The primary resolution source for this market will be a consensus of credible reporting.
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.” Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required. Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice. The primary resolution source for this market will be a consensus of credible reporting.
Volume
$21,914
Data de Término
1 jul 2027
Mercado Aberto
Sep 18, 2026, 8:27 PM ET

Cuidado com os links externos.

Frequently Asked Questions

"Vazamento de laboratório antrópico por...?" is a prediction market on Polymarket with 2 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "30 de junho de 2027" at 11%, followed by "31 de dezembro de 2026" at 3%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 11¢ implies that the market collectively assigns a 11% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Vazamento de laboratório antrópico por...?" has generated $21.9K in total trading volume since the market launched on Sep 18, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Vazamento de laboratório antrópico por...?," browse the 2 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Vazamento de laboratório antrópico por...?" is "30 de junho de 2027" at 11%, meaning the market assigns a 11% chance to that outcome. The next closest outcome is "31 de dezembro de 2026" at 3%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Vazamento de laboratório antrópico por...?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.